1. Home
  2. SRPT vs LBRDP Comparison

SRPT vs LBRDP Comparison

Compare SRPT & LBRDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • LBRDP
  • Stock Information
  • Founded
  • SRPT 1980
  • LBRDP N/A
  • Country
  • SRPT United States
  • LBRDP United States
  • Employees
  • SRPT N/A
  • LBRDP 1900
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • LBRDP Cable & Other Pay Television Services
  • Sector
  • SRPT Health Care
  • LBRDP Telecommunications
  • Exchange
  • SRPT Nasdaq
  • LBRDP Nasdaq
  • Market Cap
  • SRPT 1.7B
  • LBRDP N/A
  • IPO Year
  • SRPT 1997
  • LBRDP N/A
  • Fundamental
  • Price
  • SRPT $17.97
  • LBRDP $25.12
  • Analyst Decision
  • SRPT Buy
  • LBRDP
  • Analyst Count
  • SRPT 25
  • LBRDP 0
  • Target Price
  • SRPT $61.57
  • LBRDP N/A
  • AVG Volume (30 Days)
  • SRPT 8.0M
  • LBRDP N/A
  • Earning Date
  • SRPT 08-06-2025
  • LBRDP N/A
  • Dividend Yield
  • SRPT N/A
  • LBRDP N/A
  • EPS Growth
  • SRPT N/A
  • LBRDP N/A
  • EPS
  • SRPT N/A
  • LBRDP N/A
  • Revenue
  • SRPT $2,233,371,000.00
  • LBRDP N/A
  • Revenue This Year
  • SRPT $26.87
  • LBRDP N/A
  • Revenue Next Year
  • SRPT $3.15
  • LBRDP N/A
  • P/E Ratio
  • SRPT N/A
  • LBRDP N/A
  • Revenue Growth
  • SRPT 59.15
  • LBRDP N/A
  • 52 Week Low
  • SRPT $16.88
  • LBRDP N/A
  • 52 Week High
  • SRPT $154.13
  • LBRDP N/A
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 28.43
  • LBRDP 66.35
  • Support Level
  • SRPT $17.31
  • LBRDP $24.84
  • Resistance Level
  • SRPT $19.74
  • LBRDP $25.13
  • Average True Range (ATR)
  • SRPT 1.04
  • LBRDP 0.16
  • MACD
  • SRPT 0.87
  • LBRDP -0.00
  • Stochastic Oscillator
  • SRPT 45.83
  • LBRDP 82.22

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

Share on Social Networks: